| abstract |
A corticotropin releasing factor (CRF) antagonist is administered to treat a condition selected from the group consisting of: n c) disorders that can be treated by altering circadian rhythm; and n d) depression, further wherein a second compound for treating depression is administered, the second compound for treating depression having an onset of action that is delayed with respect to that of the CRF antagonist. |